DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue S 2 · Volume 24 · May 2004 DOI: 10.1055/s-002-3577 Chronic Hepatitis C Editor in Chief Paul D Berk M.D., Guest Editor Mitchell L Shiffman M.D.

INTRODUCTION

  • 1
    Shiffman, Mitchell L.:

    Chronic Hepatitis C

  • 3
    Afdhal, Nezam H.:

    The Natural History of Hepatitis C

  • 9
    Ferreira-Gonzalez, Andrea; Shiffman, Mitchell L.:

    Use of Diagnostic Testing for Managing Hepatitis C Virus Infection

  • 19
    Poynard, Thierry:

    Treatment of Hepatitis C Virus: The First Decade

  • 25
    Ferenci, Peter:

    Predictors of Response to Therapy for Chronic Hepatitis C

  • 33
    Reddy, K. Rajender:

    Development and Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Alfa-2a (40 kD)

  • 39
    Heathcote, Jenny; Zeuzem, Stefan:

    Pegylated Interferon Monotherapy for Chronic Hepatitis C

  • 47
    Fried, Michael W.; Hadziyannis, Stephanos J.:

    Treatment of Chronic Hepatitis C Infection with Peginterferons Plus Ribavirin

  • 55
    Lee, Samuel S.:

    Histological Response to Interferon Alfa-Based Therapies in Hepatitis C

  • 61
    Sterling, Richard K.; Sulkowski, Mark S.:

    Hepatitis C Virus in the Setting of HIV or Hepatitis B Virus Coinfection

  • 69
    Poordad, Fred F.; Fabrizi, Fabrizio; Martin, Paul:

    Hepatitis C Infection Associated with Renal Disease and Chronic Renal Failure

  • 79
    Charlton, Michael; Wiesner, Russell:

    Natural History and Management of Hepatitis C Infection After Liver Transplantation

  • 89
    Brillanti, Stefano:

    Role of Amantadine and Other Adjuvant Therapies in the Treatment of Hepatitis C

  • 97
    Foster, Graham R.:

    Past, Present, and Future Hepatitis C Treatments